The Change of Plasma Ghrelin and Leptin Levels by the Development of Type 2 Diabetes Mellitus in Patients With Alcohol Dependence

Authors

  • Anes Ju,

    1. From the Department of Biomedical Science (AJ, DJK), The Catholic University of Korea College of Medicine, Seoul, South Korea; Department of Psychiatry (YHC), Incheon Chamsarang Hospital, Seojin Medical Research Institute, Incheon, South Korea; Department of Psychiatry (KSL), Addiction Center, Seoul National Hospital, An affiliate of Ministry for Health, Welfare & Family Affairs, Seoul, South Korea; Division of Endocrinology and Metabolism (SSL), Department of Internal Medicine, Bucheon St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Bucheon, South Korea; Division of Endocrinology and Metabolism (WYL), Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea; Department of Psychiatry (WYW, DJK), Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Seoul, South Korea; and Division of Intractable Diseases (SIP, WHK), Center for Biomedical Sciences, National Institutes of Health in Korea (KNIH), Seoul, South Korea.
    Search for more papers by this author
  • Young-Hoon Cheon,

    1. From the Department of Biomedical Science (AJ, DJK), The Catholic University of Korea College of Medicine, Seoul, South Korea; Department of Psychiatry (YHC), Incheon Chamsarang Hospital, Seojin Medical Research Institute, Incheon, South Korea; Department of Psychiatry (KSL), Addiction Center, Seoul National Hospital, An affiliate of Ministry for Health, Welfare & Family Affairs, Seoul, South Korea; Division of Endocrinology and Metabolism (SSL), Department of Internal Medicine, Bucheon St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Bucheon, South Korea; Division of Endocrinology and Metabolism (WYL), Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea; Department of Psychiatry (WYW, DJK), Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Seoul, South Korea; and Division of Intractable Diseases (SIP, WHK), Center for Biomedical Sciences, National Institutes of Health in Korea (KNIH), Seoul, South Korea.
    Search for more papers by this author
  • Kye-Seong Lee,

    1. From the Department of Biomedical Science (AJ, DJK), The Catholic University of Korea College of Medicine, Seoul, South Korea; Department of Psychiatry (YHC), Incheon Chamsarang Hospital, Seojin Medical Research Institute, Incheon, South Korea; Department of Psychiatry (KSL), Addiction Center, Seoul National Hospital, An affiliate of Ministry for Health, Welfare & Family Affairs, Seoul, South Korea; Division of Endocrinology and Metabolism (SSL), Department of Internal Medicine, Bucheon St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Bucheon, South Korea; Division of Endocrinology and Metabolism (WYL), Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea; Department of Psychiatry (WYW, DJK), Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Seoul, South Korea; and Division of Intractable Diseases (SIP, WHK), Center for Biomedical Sciences, National Institutes of Health in Korea (KNIH), Seoul, South Korea.
    Search for more papers by this author
  • Seong-Su Lee,

    1. From the Department of Biomedical Science (AJ, DJK), The Catholic University of Korea College of Medicine, Seoul, South Korea; Department of Psychiatry (YHC), Incheon Chamsarang Hospital, Seojin Medical Research Institute, Incheon, South Korea; Department of Psychiatry (KSL), Addiction Center, Seoul National Hospital, An affiliate of Ministry for Health, Welfare & Family Affairs, Seoul, South Korea; Division of Endocrinology and Metabolism (SSL), Department of Internal Medicine, Bucheon St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Bucheon, South Korea; Division of Endocrinology and Metabolism (WYL), Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea; Department of Psychiatry (WYW, DJK), Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Seoul, South Korea; and Division of Intractable Diseases (SIP, WHK), Center for Biomedical Sciences, National Institutes of Health in Korea (KNIH), Seoul, South Korea.
    Search for more papers by this author
  • Won-Young Lee,

    1. From the Department of Biomedical Science (AJ, DJK), The Catholic University of Korea College of Medicine, Seoul, South Korea; Department of Psychiatry (YHC), Incheon Chamsarang Hospital, Seojin Medical Research Institute, Incheon, South Korea; Department of Psychiatry (KSL), Addiction Center, Seoul National Hospital, An affiliate of Ministry for Health, Welfare & Family Affairs, Seoul, South Korea; Division of Endocrinology and Metabolism (SSL), Department of Internal Medicine, Bucheon St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Bucheon, South Korea; Division of Endocrinology and Metabolism (WYL), Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea; Department of Psychiatry (WYW, DJK), Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Seoul, South Korea; and Division of Intractable Diseases (SIP, WHK), Center for Biomedical Sciences, National Institutes of Health in Korea (KNIH), Seoul, South Korea.
    Search for more papers by this author
  • Wang-Youn Won,

    1. From the Department of Biomedical Science (AJ, DJK), The Catholic University of Korea College of Medicine, Seoul, South Korea; Department of Psychiatry (YHC), Incheon Chamsarang Hospital, Seojin Medical Research Institute, Incheon, South Korea; Department of Psychiatry (KSL), Addiction Center, Seoul National Hospital, An affiliate of Ministry for Health, Welfare & Family Affairs, Seoul, South Korea; Division of Endocrinology and Metabolism (SSL), Department of Internal Medicine, Bucheon St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Bucheon, South Korea; Division of Endocrinology and Metabolism (WYL), Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea; Department of Psychiatry (WYW, DJK), Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Seoul, South Korea; and Division of Intractable Diseases (SIP, WHK), Center for Biomedical Sciences, National Institutes of Health in Korea (KNIH), Seoul, South Korea.
    Search for more papers by this author
  • Sang-Ick Park,

    1. From the Department of Biomedical Science (AJ, DJK), The Catholic University of Korea College of Medicine, Seoul, South Korea; Department of Psychiatry (YHC), Incheon Chamsarang Hospital, Seojin Medical Research Institute, Incheon, South Korea; Department of Psychiatry (KSL), Addiction Center, Seoul National Hospital, An affiliate of Ministry for Health, Welfare & Family Affairs, Seoul, South Korea; Division of Endocrinology and Metabolism (SSL), Department of Internal Medicine, Bucheon St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Bucheon, South Korea; Division of Endocrinology and Metabolism (WYL), Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea; Department of Psychiatry (WYW, DJK), Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Seoul, South Korea; and Division of Intractable Diseases (SIP, WHK), Center for Biomedical Sciences, National Institutes of Health in Korea (KNIH), Seoul, South Korea.
    Search for more papers by this author
  • Won-Ho Kim,

    1. From the Department of Biomedical Science (AJ, DJK), The Catholic University of Korea College of Medicine, Seoul, South Korea; Department of Psychiatry (YHC), Incheon Chamsarang Hospital, Seojin Medical Research Institute, Incheon, South Korea; Department of Psychiatry (KSL), Addiction Center, Seoul National Hospital, An affiliate of Ministry for Health, Welfare & Family Affairs, Seoul, South Korea; Division of Endocrinology and Metabolism (SSL), Department of Internal Medicine, Bucheon St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Bucheon, South Korea; Division of Endocrinology and Metabolism (WYL), Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea; Department of Psychiatry (WYW, DJK), Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Seoul, South Korea; and Division of Intractable Diseases (SIP, WHK), Center for Biomedical Sciences, National Institutes of Health in Korea (KNIH), Seoul, South Korea.
    Search for more papers by this author
  • Dai-Jin Kim

    1. From the Department of Biomedical Science (AJ, DJK), The Catholic University of Korea College of Medicine, Seoul, South Korea; Department of Psychiatry (YHC), Incheon Chamsarang Hospital, Seojin Medical Research Institute, Incheon, South Korea; Department of Psychiatry (KSL), Addiction Center, Seoul National Hospital, An affiliate of Ministry for Health, Welfare & Family Affairs, Seoul, South Korea; Division of Endocrinology and Metabolism (SSL), Department of Internal Medicine, Bucheon St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Bucheon, South Korea; Division of Endocrinology and Metabolism (WYL), Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea; Department of Psychiatry (WYW, DJK), Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Seoul, South Korea; and Division of Intractable Diseases (SIP, WHK), Center for Biomedical Sciences, National Institutes of Health in Korea (KNIH), Seoul, South Korea.
    Search for more papers by this author

Reprint requests: Dai-Jin Kim, MD, PhD, Department of Psychiatry, Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine, 505 Banpo-Dong, Seocho-gu, Seoul 137-701, South Korea; Tel.: 82 2 2258 6086; Fax: 82 2 594 3870; E-mail:kdj922@catholic.ac.kr

Abstract

Background:  There have been lots of studies about the relationship between chronic use of alcohol and the development of type 2 diabetes mellitus (T2DM). Chronic use of alcohol can be affected by the altered level of ghrelin and leptin which regulate food-seeking behavior having similar mechanism of controlling alcohol-craving behavior. Those peptides are known to be correlated with T2DM. Ghrelin and leptin also have been regarded as possible regulators of glucose metabolism and insulin function. Hence, there is the possibility that ghrelin and leptin can be related with deteriorated pathophysiology of T2DM in alcoholic patients.

Methods:  Patients with alcohol dependence diagnosed by Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) underwent an 75 g oral glucose-tolerance test (OGTT), to classify them to normal glucose tolerance (NGT, = 52), pre-diabetes including impaired glucose tolerance (IGT), impaired fasting glucose level (IFG) and combination of IGT and IFG (Pre-DM, = 26) and T2DM (= 24) groups. Fasting plasma ghrelin and leptin levels were compared among groups.

Results:  There was no difference of ghrelin concentration among the groups but the leptin concentration was significantly different between NGT and T2DM group (p < 0.05). Increased leptin levels were significantly correlated with body mass index (BMI), insulin level, and insulin resistance.

Conclusions:  Chronic alcohol drinking might produce leptin resistance which makes leptin significantly correlated with fasting insulin concentration and insulin resistance. Therefore, we suppose that increased level of leptin by chronic alcohol use could be one of the main mechanisms that develop insulin resistance in alcoholic patients.

Ancillary